SECURITIES AND EXCHANGE COMMISSION
(Amendment No. 16)*
(Name of Issuer)
(Title of Class of Securities)
(CUSIP Number)
(Date of Event Which Requires Filing of this Statement)
|
☐
|
Rule 13d-1(b)
|
|
☐
|
Rule 13d-1(c)
|
| ☒ |
Rule 13d-1(d)
|
| ∗ |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
|
Dr. Hasso Plattner
|
|
|
|||
|
|
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
|
(a)☐
|
|||||
|
(b)☐
|
|
|
|||
|
3
|
SEC USE ONLY
|
|
|
||
| |
|
|
|||
|
|
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
|
Federal Republic of Germany
|
|
|
|||
|
|
|
||||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
|
37,422,321
|
|
|
|||
|
|
|
||||
|
6
|
SHARED VOTING POWER
|
|
|
||
|
36,856,355*
|
|
|
|||
|
|
|
||||
|
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
|
37,422,321
|
|
|
|||
|
|
|
||||
|
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
36,856,355*
|
|
|
|||
|
|
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
|
74,278,676*
|
|
|
|||
|
|
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
|
☐
|
|
|
|||
|
|
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
|
6.2%
|
|
|
|||
|
|
|
||||
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
|
IN
|
|
|
|||
|
|
|
||||
| * |
*Includes 37,939,503 ordinary shares owned by HP Endowment GmbH & Co. KG (f/k/a HP Vermögensverwaltungs GmbH & Co. KG). Dr. Plattner exercises voting and dispositive powers with respect to
the ordinary shares held by such entity.
|
| ITEM 1(A). |
Name of Issuer.
|
| ITEM 1(B). |
Address of Issuer’s Principal Executive Offices.
|
| ITEM 2(A). |
Name of Person Filing.
|
| ITEM 2(B). |
Address of Principal Business Office or, if None, Residence.
|
| ITEM 2(C). |
Citizenship.
|
| ITEM 2(D). |
Title of Class of Securities.
|
| ITEM 2(E). |
CUSIP Number.
|
| ITEM 3. |
If this Statement is Filed Pursuant to Rules 13d-1(b) or 13d- 2(b) or (c), Check Whether the Person Filing is a:
|
| (a) |
☐ Broker or dealer registered under Section 15 of the Act,
|
| (b) |
☐ Bank as defined in Section 3(a)(6) of the Act,
|
| (c) |
☐ Insurance Company as defined in Section 3(a)(19) of the Act,
|
| (d) |
☐ Investment Company registered under Section 8 of the Investment Company Act of 1940,
|
| (e) |
☐ Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E),
|
| (f) |
☐ Employee Benefit Plan or Endowment Fund in accordance with 13d-1 (b)(1)(ii)(F),
|
| (g) |
☐ Parent Holding Company or control person in accordance with Rule 13d-1 (b)(1)(ii)(G),
|
| (h) |
☐ Savings Association as defined in Section 3 (b) of the Federal Deposit Insurance Act,
|
| (i) |
☐ Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940, or
|
| (j) |
☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
|
|
ITEM 4.
|
Ownership.
|
|
(a)
|
Amount beneficially owned: 74,278,676
|
|
(b)
|
Percent of class: 6.2%
|
|
(c) (i)
|
Sole power to vote or direct the vote: 37,422,321
|
|
(ii)
|
Shared power to vote or direct the vote: 36,856,355
|
|
(iii)
|
Sole power to dispose or direct the disposition: 37,422,321
|
|
(iv)
|
Shared power to dispose or direct the disposition: 36,856,355
|
| ITEM 5. |
Ownership of Five Percent or Less of a Class
|
| ITEM 6. |
Ownership of More Than Five Percent on Behalf of Another Person.
|
| ITEM 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
|
| ITEM 8. |
Identification and Classification of Members of the Group.
|
| ITEM 9. |
Notice of Dissolution of Group.
|
| ITEM 10. |
Certification.
|
|
Dated: February 16, 2021
|
||
|
Prof. Dr. h.c. Hasso Plattner
|
||
|
By:
|
/s/ Dr. Rouven Westphal
|
|
|
Dr. Rouven Westphal
|
||
|
Attorney-In-Fact
|
||
|
DR. HASSO PLATTNER
|
||